Research Article

You have full text access to this OnlineOpen article

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

  1. Solbritt Rantapää-Dahlqvist1,*,
  2. Ben A. W. de Jong2,
  3. Ewa Berglin1,
  4. Göran Hallmans1,
  5. Göran Wadell1,
  6. Hans Stenlund1,
  7. Ulf Sundin3,
  8. Walther J. van Venrooij2

Article first published online: 7 OCT 2003

DOI: 10.1002/art.11223

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 48, Issue 10, pages 2741–2749, October 2003

Additional Information

How to Cite

Rantapää-Dahlqvist, S., de Jong, B. A. W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U. and van Venrooij, W. J. (2003), Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis & Rheumatism, 48: 2741–2749. doi: 10.1002/art.11223

Author Information

  1. 1

    Umeå Universitet, Umea, Sweden

  2. 2

    University of Nijmegen, Nijmegen, The Netherlands

  3. 3

    Huddinge University Hospital, Stockholm, Sweden

*Department of Public Health and Clinical Medicine, Rheumatology, University Hospital, Umea 901 85, Sweden

Publication History

  1. Issue published online: 7 OCT 2003
  2. Article first published online: 7 OCT 2003
  3. Manuscript Accepted: 9 MAY 2003
  4. Manuscript Received: 9 DEC 2002

Funded by

  • King Gustaf V's 80-Year Fund
  • Swedish Rheumatism Association
  • Medical Faculty of Umea University, Umea, Sweden
  • The Netherlands Organization for Scientific Research in the Medical Sciences
  • Dutch League Against Rheumatism. Grant Number: NWO-MW grant 940-35-037
  • Council for Chemical Sciences
  • The Netherlands Technology Foundation. Grant Number: STW grant 349-5077

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (95K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rebecca C. Keith, Jennifer L. Powers, Elizabeth F. Redente, Amen Sergew, Richard J. Martin, Alison Gizinski, V. Michael Holers, Shimon Sakaguchi, David W. H. Riches, A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice, Experimental Lung Research, 2012, 38, 2, 55

    CrossRef

  2. 2
    Kristian Tore Jørgensen, Nete Munk Nielsen, Bo Vestergaard Pedersen, Søren Jacobsen, Morten Frisch, Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort, Journal of Autoimmunity, 2012,

    CrossRef

  3. 3
    D. Kanmert, A. Kastbom, G. Almroth, T. Skogh, K. Enander, J. Wetterö, IgG Rheumatoid Factors Against the Four Human Fc-gamma Subclasses in Early Rheumatoid Arthritis (The Swedish TIRA Project), Scandinavian Journal of Immunology, 2012, 75, 1
    Direct Link:
  4. 4
    Yoony Y. J. Gent, Alexandre E. Voskuyl, Reina W. Kloet, Dirkjan van Schaardenburg, Otto S. Hoekstra, Ben A. C. Dijkmans, Adriaan A. Lammertsma, Conny J. van der Laken, Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: Findings of a prospective pilot study, Arthritis & Rheumatism, 2012, 64, 1
    Direct Link:
  5. 5
    Andrea Tesija Kuna, Mutated citrullinated vimentin antibodies in rheumatoid arthritis, Clinica Chimica Acta, 2012, 413, 1-2, 66

    CrossRef

  6. 6
    Cathrin Nikolaisen, Emilio Besada, Johannes Nossent, Nye kriterier for revmatoid artritt, Tidsskrift for Den norske legeforening, 2012, 132, 2, 175

    CrossRef

  7. 7
    Annemiek Willemze, Leendert A. Trouw, René E. M. Toes, Tom W. J. Huizinga, The influence of ACPA status and characteristics on the course of RA, Nature Reviews Rheumatology, 2012,

    CrossRef

  8. 8
    Peter Taylor, Juliane Gartemann, Jeanie Hsieh, James Creeden, A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis, Autoimmune Diseases, 2011, 2011, 1

    CrossRef

  9. 9
    Hans Ulrich Scherer, Gerd-Rüdiger Burmester, Adaptive immunity in rheumatic diseases – Bystander or pathogenic player?, Best Practice & Research Clinical Rheumatology, 2011, 25, 6, 785

    CrossRef

  10. 10
    Walther J. van Venrooij, Joyce J. B. C. van Beers, Ger J. M. Pruijn, Anti-CCP antibodies: the past, the present and the future, Nature Reviews Rheumatology, 2011, 7, 7, 391

    CrossRef

  11. 11
    Parawee Suwannalai, Leendert A. Trouw, Rene E. M. Toes, Tom W. J. Huizinga, Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis, Modern Rheumatology, 2011,

    CrossRef

  12. 12
    Sylvie Pollmann, Maria Stensland, Eirik Hornes Halvorsen, Ludvig M. Sollid, Tore K. Kvien, Burkhard Fleckenstein, Øyvind Molberg, Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate, Rheumatology International, 2011,

    CrossRef

  13. 13
    M. Kristen Demoruelle, Kevin Deane, Antibodies to Citrullinated Protein Antigens (ACPAs): Clinical and Pathophysiologic Significance, Current Rheumatology Reports, 2011, 13, 5, 421

    CrossRef

  14. 14
    Gabriel J. Tobón, Jacques-Olivier Pers, Carlos A. Cañas, Adriana Rojas-Villarraga, Pierre Youinou, Juan-Manuel Anaya, Are autoimmune diseases predictable?, Autoimmunity Reviews, 2011,

    CrossRef

  15. 15
    R.A. Benson, A. Patakas, R. McQueenie, K. Ross, I.B. McInnes, J.M. Brewer, P. Garside, Arthritis in space and time – To boldly go!, FEBS Letters, 2011, 585, 23, 3640

    CrossRef

  16. 16
    Britt Nakken, Ludvig A. Munthe, Yrjö T. Konttinen, Anna Klokk Sandberg, Zoltan Szekanecz, Philip Alex, Peter Szodoray, B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives, Autoimmunity Reviews, 2011, 11, 1, 28

    CrossRef

  17. 17
    Subramanian Shankar, Yanamandra Uday, Biobanking: Basic concepts and role in rheumatology, Indian Journal of Rheumatology, 2011, 6, 3, 129

    CrossRef

  18. 18
    Ericka M. Bueno, Julie Glowacki, Biologic Foundations for Skeletal Tissue Engineering, Synthesis Lectures on Tissue Engineering, 2011, 3, 1, 1

    CrossRef

  19. 19
    Marie-Christophe Boissier, Cell and cytokine imbalances in rheumatoid synovitis, Joint Bone Spine, 2011, 78, 3, 230

    CrossRef

  20. 20
    Paola Conigliaro, Robert A. Benson, Agapitos Patakas, Sharon M. Kelly, Guido Valesini, Rikard Holmdahl, James M. Brewer, Iain B. McInnes, Paul Garside, Characterization of the anticollagen antibody response in a new model of chronic polyarthritis, Arthritis & Rheumatism, 2011, 63, 8
    Direct Link:
  21. 21
    Anne-Marie Quirke, Benjamin A.C. Fisher, Andrew J. Kinloch, Patrick J. Venables, Citrullination of autoantigens: Upstream of TNFα in the pathogenesis of rheumatoid arthritis, FEBS Letters, 2011, 585, 23, 3681

    CrossRef

  22. 22
    Nina A. Daha, Nirmal K. Banda, Anja Roos, Frank J. Beurskens, Joost M. Bakker, Mohamed R. Daha, Leendert A. Trouw, Complement activation by (auto-) antibodies, Molecular Immunology, 2011, 48, 14, 1656

    CrossRef

  23. 23
    Doreen Dobritzsch, Ingrid Lindh, Hüseyin Uysal, Kutty S. Nandakumar, Harald Burkhardt, Gunter Schneider, Rikard Holmdahl, Crystal structure of an arthritogenic anticollagen immune complex, Arthritis & Rheumatism, 2011, 63, 12
    Direct Link:
  24. 24
    Hirofumi Shoda, Keishi Fujio, Mihoko Shibuya, Tomohisa Okamura, Shuji Sumitomo, Akiko Okamoto, Tetsuji Sawada, Kazuhiko Yamamoto, Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis, Arthritis Research & Therapy, 2011, 13, 6, R191

    CrossRef

  25. 25
    Lotte A. van de Stadt, Margret H. M. T. de Koning, Rob J. van de Stadt, Gertjan Wolbink, Ben A. C. Dijkmans, Dörte Hamann, Dirkjan van Schaardenburg, Development of the anti–citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis, Arthritis & Rheumatism, 2011, 63, 11
    Direct Link:
  26. 26
    Ignazio Olivieri, Piercarlo Sarzi-Puttini, Serena Bugatti, Fabiola Atzeni, Salvatore d'Angelo, Roberto Caporali, Early treatment in early undifferentiated arthritis, Autoimmunity Reviews, 2011,

    CrossRef

  27. 27
    Omri Snir, Mary Rieck, John A. Gebe, Betty B. Yue, Crystal A. Rawlings, Gerald Nepom, Vivianne Malmström, Jane H. Buckner, Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA–DRB1*0401–positive humanized mice and rheumatoid arthritis patients, Arthritis & Rheumatism, 2011, 63, 10
    Direct Link:
  28. 28
    Karen H. Costenbader, Jennifer Prescott, Robert Y. Zee, Immaculata De Vivo, Immunosenescence and rheumatoid arthritis: Does telomere shortening predict impending disease?, Autoimmunity Reviews, 2011, 10, 9, 569

    CrossRef

  29. 29
    Hui-Chen Hsu, PingAr Yang, Qi Wu, John H. Wang, Godwin Job, Tanja Guentert, Jun Li, Cecil R. Stockard, Thuc-vy L. Le, David D. Chaplin, William E. Grizzle, John D. Mountz, Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice, Arthritis & Rheumatism, 2011, 63, 7
    Direct Link:
  30. 30
    Per Matsson, Is there a future for multiplexed technologies in the point-of-care setting?, Bioanalysis, 2011, 3, 18, 2049

    CrossRef

  31. 31
    Falk Hiepe, Thomas Dörner, Anja E. Hauser, Bimba F. Hoyer, Henrik Mei, Andreas Radbruch, Long-lived autoreactive plasma cells drive persistent autoimmune inflammation, Nature Reviews Rheumatology, 2011, 7, 3, 170

    CrossRef

  32. 32
    Cecilia Carnrot, Kajsa E Prokopec, Kristina RÃ¥sbo, Mikael CI Karlsson, Sandra Kleinau, Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis, Cellular and Molecular Immunology, 2011, 8, 4, 296

    CrossRef

  33. 33
    Karsten Conrad, Prädiktive Bedeutung von Autoantikörpern/Predictive relevance of autoantibodies, LaboratoriumsMedizin, 2011, 35, 6, 363

    CrossRef

  34. 34
    I.C. Scott, S. Steer, C.M. Lewis, A.P. Cope, Precipitating and perpetuating factors of rheumatoid arthritis immunopathology – linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 447

    CrossRef

  35. 35
    You Jung Ha, Yong-Beom Park, Myoung-Kyun Son, Sang-Youn Jung, Kwang-Hoon Lee, Soo-Kon Lee, Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis, Rheumatology International, 2011,

    CrossRef

  36. 36
    Marianne Wallenius, Johan F. Skomsvoll, Lorentz M. Irgens, Kjell Å. Salvesen, Bjorn Y. Nordvåg, Wenche Koldingsnes, Knut Mikkelsen, Cecilie Kaufmann, Tore K. Kvien, Pregnancy and delivery in women with chronic inflammatory arthritides with a specific focus on first birth, Arthritis & Rheumatism, 2011, 63, 6
    Direct Link:
  37. 37
    Kyle M Walker, Mateusz Rytelewski, Delfina M Mazzuca, Shannon A Meilleur, Lisa A Mannik, David Yue, William C Brintnell, Ian Welch, Ewa Cairns, S M Mansour Haeryfar, Preventing and curing citrulline-induced autoimmune arthritis in a humanized mouse model using a Th2-polarizing iNKT cell agonist, Immunology and Cell Biology, 2011,

    CrossRef

  38. You have free access to this content38
    K. H. Costenbader, Rheumatic disease research and implications for clinical care, International Journal of Clinical Practice, 2011, 65, 6
    Direct Link:
  39. 39
    Mohamed Elrefaei, Kristie Boose, Martha McGee, Teresa K. Tarrant, Feng-Chang Lin, Jason P. Fine, John L. Schmitz, Second Generation Automated Anti-CCP Test Better Predicts the Clinical Diagnosis of Rheumatoid Arthritis, Journal of Clinical Immunology, 2011,

    CrossRef

  40. 40
    Lars Klareskog, Vivianne Malmström, Karin Lundberg, Leonid Padyukov, Lars Alfredsson, Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis, Seminars in Immunology, 2011, 23, 2, 92

    CrossRef

  41. 41
    Annemiek Willemze, Diane van der Woude, Wendimagegn Ghidey, E. W. Nivine Levarht, Gerrie Stoeken-Rijsbergen, Willem Verduyn, René R. P. de Vries, Jeanine J. Houwing-Duistermaat, Tom W. J. Huizinga, Leendert A. Trouw, René E. M. Toes, The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens, Arthritis & Rheumatism, 2011, 63, 7
    Direct Link:
  42. 42
    Iain B. McInnes, Georg Schett, The Pathogenesis of Rheumatoid Arthritis, New England Journal of Medicine, 2011, 365, 23, 2205

    CrossRef

  43. 43
    Edmund Luke GOMEZ, Suk Chyn GUN, Sushela Devi SOMNATH, Beryl D’SOUZA, Ai Lee LIM, Karuthan CHINNA, Ammu K RADHAKRISHNAN, The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients, International Journal of Rheumatic Diseases, 2011, 14, 1
    Direct Link:
  44. 44
    Ronald F. van Vollenhoven, Unresolved issues in biologic therapy for rheumatoid arthritis, Nature Reviews Rheumatology, 2011, 7, 4, 205

    CrossRef

  45. 45
    Nicola Bizzaro, Martinus A. M. Boekel, Ron Verheijen, Valutazione analitica e clinica di un nuovo metodo immunocromogenico per la rilevazione in point-of-care di anticorpi anti-peptidi citrullinati, La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine, 2011, 7, 3, 156

    CrossRef

  46. 46
    Dalila Mrabet, Lilia Laadhar, Héla Sahli, Béchir Zouari, Slim Haouet, Houria Lahmar, Sondes Makni, Slaheddine Sellami, What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study, Clinical Rheumatology, 2011, 31, 2, 375

    CrossRef

  47. 47
    Alan M. Rosenberg, Kiem G. Oen, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  48. 48
    Ankit Saxena, Smriti Raychaudhuri, Arthritis, 2011,

    CrossRef

  49. 49
    Daniel Aletaha, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham, Neal S. Birnbaum, Gerd R. Burmester, Vivian P. Bykerk, Marc D. Cohen, Bernard Combe, Karen H. Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna M. W. Hazes, Kathryn Hobbs, Tom W. J. Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K. Kvien, Timothy Laing, Philip Mease, Henri A. Ménard, Larry W. Moreland, Raymond L. Naden, Theodore Pincus, Josef S. Smolen, Ewa Stanislawska-Biernat, Deborah Symmons, Paul P. Tak, Katherine S. Upchurch, Jiří Vencovský, Frederick Wolfe, Gillian Hawker, 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis & Rheumatism, 2010, 62, 9
    Direct Link:
  50. 50
    Bing Lu, Daniel H. Solomon, Karen H. Costenbader, Brendan T. Keenan, Lori B. Chibnik, Elizabeth W. Karlson, Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 12
    Direct Link:
  51. 51
    Allan S. Wiik, Walther J. van Venrooij, Ger J.M. Pruijn, All you wanted to know about anti-CCP but were afraid to ask, Autoimmunity Reviews, 2010, 10, 2, 90

    CrossRef

  52. 52
    K. Ohmura, C. Terao, E. Maruya, M. Katayama, K. Matoba, K. Shimada, A. Murasawa, S. Honjo, K. Takasugi, S. Tohma, K. Matsuo, K. Tajima, N. Yukawa, D. Kawabata, T. Nojima, T. Fujii, R. Yamada, H. Saji, F. Matsuda, T. Mimori, Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis, Rheumatology, 2010, 49, 12, 2298

    CrossRef

  53. 53
    R. Gupta, M. M. Thabah, B. Vaidya, S. Gupta, R. Lodha, S. K. Kabra, Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis, The Indian Journal of Pediatrics, 2010, 77, 1, 41

    CrossRef

  54. 54
    Bogdan Kolarz, Maria Majdan, Magdalena Dryglewska, Dorota Darmochwal-Kolarz, Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis, Rheumatology International, 2010, 31, 11, 1439

    CrossRef

  55. 55
    Andrea Tesija-Kuna, Simeon Grazio, Marijana Miler, Ines Vukasovic, Porin Peric, Nada Vrkic, Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis, Clinical Rheumatology, 2010, 29, 5, 487

    CrossRef

  56. 56
    Hüseyin Uysal, Kutty Selva Nandakumar, Christoph Kessel, Sabrina Haag, Stefan Carlsen, Harald Burkhardt, Rikard Holmdahl, Antibodies to citrullinated proteins: molecular interactions and arthritogenicity, Immunological Reviews, 2010, 233, 1
    Direct Link:
  57. 57
    Omri Snir, Mona Widhe, Monika Hermansson, Caroline von Spee, Johan Lindberg, Sanne Hensen, Karin Lundberg, Åke Engström, Patrick J. W. Venables, René E. M. Toes, Rikard Holmdahl, Lars Klareskog, Vivianne Malmström, Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients, Arthritis & Rheumatism, 2010, 62, 1
    Direct Link:
  58. 58
    Allan S. Wiik, Mimi Høier-Madsen, Jan Forslid, Peter Charles, Jan Meyrowitsch, Antinuclear antibodies: A contemporary nomenclature using HEp-2 cells, Journal of Autoimmunity, 2010, 35, 3, 276

    CrossRef

  59. 59
    Albert J. Czaja, Autoantibodies as Prognostic Markers in Autoimmune Liver Disease, Digestive Diseases and Sciences, 2010, 55, 8, 2144

    CrossRef

  60. 60
    Jason R. Kolfenbach, Kevin D. Deane, Lezlie A. Derber, Colin I. O'Donnell, William R. Gilliland, Jess D. Edison, Antony Rosen, Erika Darrah, Jill M. Norris, V. Michael Holers, Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 9
    Direct Link:
  61. 61
    Natalia Wegner, Karin Lundberg, Andrew Kinloch, Benjamin Fisher, Vivianne Malmström, Marc Feldmann, Patrick J. Venables, Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis, Immunological Reviews, 2010, 233, 1
    Direct Link:
  62. 62
    Fiona McQueen, Bob Elliott, B cell lymphoproliferation and organ-directed self-recognition to explain autoimmunity: Back to the past, Medical Hypotheses, 2010, 75, 3, 328

    CrossRef

  63. 63
    Tamsin M. Lindstrom, William H. Robinson, Biomarkers for rheumatoid arthritis: Making it personal, Scandinavian Journal of Clinical & Laboratory Investigation, 2010, 70, s242, 79

    CrossRef

  64. 64
    Margaret T. Agyei-Frem, Samuel A. Sakyi, Robert E. Quansah, Comparison of Anti-CCP Peptide with Rheumatoid Factor and its Isotypes for Early Differential Diagnosis and Prognosis of Rheumatoid Arthritis, Journal of Medical Sciences(Faisalabad), 2010, 10, 1, 19

    CrossRef

  65. 65
    Kumi Shidara, Eisuke Inoue, Eiichi Tanaka, Daisuke Hoshi, Yohei Seto, Ayako Nakajima, Shigeki Momohara, Atsuo Taniguchi, Hisashi Yamanaka, Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis, Rheumatology International, 2010, 31, 5, 617

    CrossRef

  66. 66
    Shunsuke Mori, Jun Hirose, Kensuke Yonemura, Contribution of HLA-DRB1*04 alleles and anti-cyclic citrullinated antibodies to development of resistance to disease-modifying antirheumatic drugs in early rheumatoid arthritis, Clinical Rheumatology, 2010, 29, 12, 1357

    CrossRef

  67. 67
    David Yue, William Brintnell, Lisa A. Mannik, Darah A. Christie, S. M. Mansour Haeryfar, Joaquín Madrenas, Subrata Chakrabarti, David A. Bell, Ewa Cairns, CTLA-4Ig blocks the development and progression of citrullinated fibrinogen–induced arthritis in DR4-transgenic mice, Arthritis & Rheumatism, 2010, 62, 10
    Direct Link:
  68. 68
    Zsolt B Nagy, Mónika Csanád, Katalin Tóth, Balázs Börzsönyi, Csaba Demendi, János Rigó Jr, József Gábor Joó, Current concepts in the genetic diagnostics of rheumatoid arthritis, Expert Review of Molecular Diagnostics, 2010, 10, 5, 603

    CrossRef

  69. 69
    Lie Ying Fan, Ming Zong, Qiang Wang, Lin Yang, Li Shan Sun, Qin Ye, Yuan Yuan Ding, Jian Wei Ma, Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis, Clinica Chimica Acta, 2010, 411, 23-24, 2049

    CrossRef

  70. 70
    Kajsa E. Prokopec, Mia Rhodiner, Peter Matt, Ulla Lindqvist, Sandra Kleinau, Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis, Clinical Immunology, 2010, 137, 3, 322

    CrossRef

  71. 71
    G. Valentini, G. Cuomo, G. Abignano, A. Petrillo, S. Vettori, A. Capasso, D. Cozzolino, G. Del Genio, C. Santoriello, Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features, Rheumatology, 2010, 50, 2, 317

    CrossRef

  72. 72
    Lisa G. M. van Baarsen, Wouter H. Bos, François Rustenburg, Tineke C. T. M. van der Pouw Kraan, Gerrit Jan J. Wolbink, Ben A. C. Dijkmans, Dirkjan van Schaardenburg, Cornelis L. Verweij, Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis, Arthritis & Rheumatism, 2010, 62, 3
    Direct Link:
  73. 73
    Hans U. Scherer, Diane van der Woude, Andreea Ioan-Facsinay, Hanane el Bannoudi, Leendert A. Trouw, Jun Wang, Thomas Häupl, Gerd-R. Burmester, André M. Deelder, Tom W. J. Huizinga, Manfred Wuhrer, René E. M. Toes, Glycan profiling of anti–citrullinated protein antibodies isolated from human serum and synovial fluid, Arthritis & Rheumatism, 2010, 62, 6
    Direct Link:
  74. 74
    Anouk L. Feitsma, Ellen I. H. van der Voort, Kees L. M. C. Franken, Hanane El Bannoudi, Berendina G. Elferink, Jan W. Drijfhout, Tom W. J. Huizinga, René R. P. de Vries, René E. M. Toes, A. Ioan-Facsinay, Identification of citrullinated vimentin peptides as T cell epitopes in HLA–DR4–positive patients with rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 1
    Direct Link:
  75. 75
    Jun-feng HAO, Yu-bao WEI, Rui-wen CHEN, Identifying susceptible genes of rheumatoid arthritis by genome-wide association study:an advance, Academic Journal of Second Military Medical University, 2010, 29, 11, 1303

    CrossRef

  76. 76
    E Berglin, H Kokkonen, E Einarsdottir, Å Ågren, S Rantapää Dahlqvist, Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case–control study, Scandinavian Journal of Rheumatology, 2010, 39, 6, 454

    CrossRef

  77. 77
    Angelica Gierut, Harris Perlman, Richard M. Pope, Innate Immunity and Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2010, 36, 2, 271

    CrossRef

  78. 78
    Dina Shahin, Ehab Eltoraby, Abeer Mesbah, Maha Houssen, Insulin resistance in early untreated rheumatoid arthritis patients, Clinical Biochemistry, 2010, 43, 7-8, 661

    CrossRef

  79. 79
    Usha Singh, Anjali Vishwanath, Pramod K. Verma, Nand K. Singh, Ram C. Shukla, Sangeeta Singh, Suman Singh, Gyanendra K. Sonkar, Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis?, Rheumatology International, 2010, 30, 8, 1115

    CrossRef

  80. 80
    Nancy A. Shadick, Elizabeth W. Karlson, Nancy R. Cook, Nancy E. Maher, Julie E. Buring, I-Min Lee, Low-dose aspirin in the primary prevention of rheumatoid arthritis: The women's health study, Arthritis Care & Research, 2010, 62, 4
    Direct Link:
  81. 81
    R.H. Straub, A. Fassold, Neuroendokrin-immune Interaktionen bei rheumatischen Krankheiten, Zeitschrift für Rheumatologie, 2010, 69, 4, 340

    CrossRef

  82. 82
    Sara P. Wyness, Sonia L. La'ulu, Joshua J.H. Hunsaker, Anne E. Tebo, William L. Roberts, Performance characteristics of three random access cyclic citrullinated peptide antibody assays, Clinica Chimica Acta, 2010, 411, 5-6, 428

    CrossRef

  83. 83
    Karin Lundberg, Natalia Wegner, Tülay Yucel-Lindberg, Patrick J. Venables, Periodontitis in RA—the citrullinated enolase connection, Nature Reviews Rheumatology, 2010, 6, 12, 727

    CrossRef

  84. 84
    Kevin D. Deane, Jill M. Norris, V. Michael Holers, Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for Investigation, Rheumatic Disease Clinics of North America, 2010, 36, 2, 213

    CrossRef

  85. 85
    Yasser Emad, Mohamed Shehata, Yasser Ragab, Ahmed Saad, Hosny Hamza, Alaa Abou-Zeid, Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis, Modern Rheumatology, 2010, 20, 4, 358

    CrossRef

  86. 86
    Karsten Conrad, Dirk Roggenbuck, Dirk Reinhold, Thomas Dörner, Profiling of rheumatoid arthritis associated autoantibodies, Autoimmunity Reviews, 2010, 9, 6, 431

    CrossRef

  87. 87
    John B. Waits, Rational Use of Laboratory Testing in the Initial Evaluation of Soft Tissue and Joint Complaints, Primary Care: Clinics in Office Practice, 2010, 37, 4, 673

    CrossRef

  88. 88
    Hiroko Nakatsukasa, Mitsutoshi Tsukimoto, Akihiro Tokunaga, Shuji Kojima, Repeated Gamma Irradiation Attenuates Collagen-Induced Arthritis via Up-regulation of Regulatory T Cells but not by Damaging Lymphocytes Directly, Radiation Research, 2010, 174, 3, 313

    CrossRef

  89. 89
    Tamsin M. Lindstrom, William H. Robinson, Rheumatoid Arthritis: A Role for Immunosenescence?, Journal of the American Geriatrics Society, 2010, 58, 8
    Direct Link:
  90. 90
    Antonio Manzo, Michele Bombardieri, Frances Humby, Costantino Pitzalis, Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling, Immunological Reviews, 2010, 233, 1
    Direct Link:
  91. 91
    Martina Fabris, Salvatore Vita, Nadia Blasone, Daniela Visentini, Elena Pezzarini, Elena Pontarini, Cinzia Fabro, Luca Quartuccio, Saulle Mazzolini, Francesco Curcio, Elio Tonutti, Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab, Autoimmunity Highlights, 2010, 1, 2, 87

    CrossRef

  92. 92
    Julia U. Holle, Stefan Wieczorek, Wolfgang L. Gross, The Future of ANCA-associated Vasculitis, Rheumatic Disease Clinics of North America, 2010, 36, 3, 609

    CrossRef

  93. 93
    R. Engelmann, M. Eggert, G. Neeck, B. Mueller-Hilke, The impact of HLA-DRB alleles on the subclass titres of antibodies against citrullinated peptides, Rheumatology, 2010, 49, 10, 1862

    CrossRef

  94. 94
    Kevin D. Deane, Colin I. O'Donnell, Wolfgang Hueber, Darcy S. Majka, Ann A. Lazar, Lezlie A. Derber, William R. Gilliland, Jess D. Edison, Jill M. Norris, William H. Robinson, V. Michael Holers, The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner, Arthritis & Rheumatism, 2010, 62, 11
    Direct Link:
  95. 95
    Ruiwen Chen, Yubao Wei, Qing Cai, Shiwei Duan, Daming Ren, Jie Shen, Dongyi He, Meng Fang, Ke Lv, Ning Cheng, Shuhan Sun, The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population, Rheumatology International, 2010, 31, 12, 1631

    CrossRef

  96. 96
    Yeong Wook Song, Eun Ha Kang, The pathogenic role of rheumatoid factor in rheumatoid arthritis, International Journal of Clinical Rheumatology, 2010, 5, 6, 651

    CrossRef

  97. 97
    Ann Duskin, Robert A. Eisenberg, The role of antibodies in inflammatory arthritis, Immunological Reviews, 2010, 233, 1
    Direct Link:
  98. 98
    L. A. Trouw, T. W. J. Huizinga, Which elements of the criteria for RA are stable over time?, Rheumatology, 2010, 50, 2, 248

    CrossRef

  99. 99
    N. Perdigones, J. R. Lamas, A. G. Vigo, E. G. de la Concha, J. A. Jover, E. Urcelay, B.-F. Gutierrez, A. Martinez, 6q23 polymorphisms in rheumatoid arthritis Spanish patients, Rheumatology, 2009, 48, 6, 618

    CrossRef

  100. 100
    Hans Ulrich Scherer, Gerd R. Burmester, A clinical perspective of rheumatoid arthritis, European Journal of Immunology, 2009, 39, 8
    Direct Link:
  101. 101
    Jason R. Kolfenbach, Kevin D. Deane, Lezlie A. Derber, Colin O'Donnell, Michael H. Weisman, Jane H. Buckner, Vivian H. Gersuk, Shan Wei, Ted R. Mikuls, James O'Dell, Peter K. Gregersen, Richard M. Keating, Jill M. Norris, V. Michael Holers, A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA, Arthritis Care & Research, 2009, 61, 12
    Direct Link:
  102. 102
    Peter Lea, Edward Keystone, Sasi Mudumba, Anthony Kahama, Shi-Fa Ding, Jennifer Hansen, Azar A. Azad, Sihe Wang, Deborah Weber, Advantages of Multiplex Proteomics in Clinical Immunology, Clinical Reviews in Allergy & Immunology, 2009, 41, 1, 20

    CrossRef

  103. 103
    M. Labrador-Horrillo, M  A. Martinez, A. Selva-O'Callaghan, J. F. Delgado, X. Martinez-Gomez, E. Trallero-Araguas, J. L. Rodriguez-Sanchez, M. Vilardell-Tarres, Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy, Rheumatology, 2009, 48, 6, 676

    CrossRef

  104. 104
    Wafaa M. Ezzat, Hala M. Raslan, Azza A. Aly, Nahed A. Emara, Manal M. El Menyawi, Amr Edrees, Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy, Rheumatology International, 2009, 31, 1, 65

    CrossRef

  105. 105
    Rohit Aggarwal, Katherine Liao, Raj Nair, Sarah Ringold, Karen H. Costenbander, Anti–citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis, Arthritis Care & Research, 2009, 61, 11
    Direct Link:
  106. 106
    L. A. Trouw, E. M. Haisma, E. W. N. Levarht, D. van der Woude, A. Ioan-Facsinay, M. R. Daha, T. W. J. Huizinga, R. E. Toes, Anti–cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways, Arthritis & Rheumatism, 2009, 60, 7
    Direct Link:
  107. 107
    Marc C. Levesque, Zhijie Zhou, Larry W. Moreland, Anti–cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value, Arthritis & Rheumatism, 2009, 60, 8
    Direct Link:
  108. 108
    Ernst Wagner, M. Skoumal, P. M. Bayer, K. Klaushofer, Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis, Rheumatology International, 2009, 29, 11, 1315

    CrossRef

  109. 109
    Licia Maria Henrique Mota, Leopoldo Luiz Santos Neto, Jozélio Freire Carvalho, Autoantibodies and other serological markers in rheumatoid arthritis: predictors of disease activity?, Clinical Rheumatology, 2009, 28, 10, 1127

    CrossRef

  110. 110
    Y.W. Song, E.H. Kang, Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies, QJM, 2009, 103, 3, 139

    CrossRef

  111. 111
    Elizabeth W. Karlson, Lori B. Chibnik, Shelley S. Tworoger, I-Min Lee, Julie E. Buring, Nancy A. Shadick, JoAnn E. Manson, Karen H. Costenbader, Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies, Arthritis & Rheumatism, 2009, 60, 3
    Direct Link:
  112. 112
    Dirkjan van Schaardenburg, Ben A. C. Dijkmans, Clinical approaches to early inflammatory arthritis, Nature Reviews Rheumatology, 2009, 5, 11, 627

    CrossRef

  113. 113
    Azad Aziz, Chi H Wong, Paul Emery, Michael F McDermott, Comparison of autoinflammation and autoimmunity using TRAPS and rheumatoid arthritis as prototypes of these conditions, International Journal of Clinical Rheumatology, 2009, 4, 6, 681

    CrossRef

  114. 114
    Vincent Goëb, Fabienne Jouen, Danièle Gilbert, Xavier Le Loët, François Tron, Olivier Vittecoq, Diagnostic and prognostic usefulness of antibodies to citrullinated peptides, Joint Bone Spine, 2009, 76, 4, 343

    CrossRef

  115. 115
    Behzad Heidari, Hassan Abedi, Alireza Firouzjahi, Parnaz Heidari, Diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody for rheumatoid arthritis, Rheumatology International, 2009, 30, 11, 1465

    CrossRef

  116. 116
    Cristina Moraes Junta, Paula Sandrin-Garcia, Ana Lúcia Fachin-Saltoratto, Stephano Spanó Mello, Renê D. R. Oliveira, Diane Meyre Rassi, Silvana Giuliatti, Elza Tiemi Sakamoto-Hojo, Paulo Louzada-Junior, Eduardo Antonio Donadi, Geraldo A. S. Passos, Differential gene expression of peripheral blood mononuclear cells from rheumatoid arthritis patients may discriminate immunogenetic, pathogenic and treatment features, Immunology, 2009, 127, 3
    Direct Link:
  117. 117
    Axel Finckh, Early inflammatory arthritis versus rheumatoid arthritis, Current Opinion in Rheumatology, 2009, 21, 2, 118

    CrossRef

  118. 118
    Katherine P Liao, Lars Alfredsson, Elizabeth W Karlson, Environmental influences on risk for rheumatoid arthritis, Current Opinion in Rheumatology, 2009, 21, 3, 279

    CrossRef

  119. 119
    Emeli Lundström, Henrik Källberg, Lars Alfredsson, Lars Klareskog, Leonid Padyukov, Gene–environment interaction between the DRB1 shared epitope and smoking in the risk of anti–citrullinated protein antibody–positive rheumatoid arthritis: All alleles are important, Arthritis & Rheumatism, 2009, 60, 6
    Direct Link:
  120. 120
    Guilherme Liberato Silva, Cristina Moraes Junta, Elza Tiemi Sakamoto-Hojo, Eduardo Antonio Donadi, Paulo Louzada-Junior, Geraldo A. S. Passos, Genetic Susceptibility Loci in Rheumatoid Arthritis Establish Transcriptional Regulatory Networks with Other Genes, Annals of the New York Academy of Sciences, 2009, 1173, 1
    Direct Link:
  121. 121
    Saurabh Ghosh, Genome-wide association analyses of quantitative traits: the GAW16 experience, Genetic Epidemiology, 2009, 33, S1
    Direct Link:
  122. 122
    Katherine P. Liao, Karen H. Costenbader, Getting them even earlier: Identifying individuals before clinical presentation with rheumatoid arthritis, Arthritis Care & Research, 2009, 61, 12
    Direct Link:
  123. 123
    Koichiro OHMURA, Is rheumatoid arthritis without anti-citrullinated peptide antibody a genetically distinct subset?, Japanese Journal of Clinical Immunology, 2009, 32, 6, 484

    CrossRef

  124. 124
    Lars Klareskog, Sara Wedrén, Lars Alfredsson, On the origins of complex immune-mediated disease: the example of rheumatoid arthritis, Journal of Molecular Medicine, 2009, 87, 4, 357

    CrossRef

  125. 125
    Emeli Lundström, Henrik Källberg, Marina Smolnikova, Bo Ding, Johan Rönnelid, Lars Alfredsson, Lars Klareskog, Leonid Padyukov, Opposing effects of HLA–DRB1*13 alleles on the risk of developing anti–citrullinated protein antibody–positive and anti–citrullinated protein antibody–negative rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 4
    Direct Link:
  126. 126
    PÃ¥l Stenberg, Bodil Roth, Frank A. Wollheim, Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis, European Journal of Internal Medicine, 2009, 20, 8, 749

    CrossRef

  127. 127
    Andrzej Surdacki, Jens Martens-Lobenhoffer, Alicja Wloch, Piotr Gluszko, Tomasz Rakowski, Jacek S. Dubiel, Stefanie M. Bode-Böger, Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration, Metabolism, 2009, 58, 3, 316

    CrossRef

  128. 128
    Sargunan SOCKALINGAM, Chow Sook KHUAN, Pavai STHANESHWAR, Prevalence of anti cyclic citrullinated peptide antibodies in Malaysian rheumatoid arthritis patients and its correlation with disease activity, International Journal of Rheumatic Diseases, 2009, 12, 3
    Direct Link:
  129. 129
    Göran Tornling, Maryam Fathi, Ingrid E Lundberg, Pulmonary involvement in polymyositis and dermatomyositis, International Journal of Clinical Rheumatology, 2009, 4, 1, 45

    CrossRef

  130. 130
    Diane van der Woude, Jeanine J. Houwing-Duistermaat, René E. M. Toes, Tom W. J. Huizinga, Wendy Thomson, Jane Worthington, Annette H. M. van der Helm-van Mil, René R. P. de Vries, Quantitative heritability of anti–citrullinated protein antibody–positive and anti–citrullinated protein antibody–negative rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 4
    Direct Link:
  131. 131
    Ann W. Morgan, Wendy Thomson, Stephen G. Martin, Angela M. Carter, Henry A. Erlich, Anne Barton, Lynne Hocking, David M. Reid, Pille Harrison, Paul Wordsworth, Sophia Steer, Jane Worthington, Paul Emery, Anthony G. Wilson, Jennifer H. Barrett, Reevaluation of the interaction between HLA–DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population, Arthritis & Rheumatism, 2009, 60, 9
    Direct Link:
  132. 132
    Lars Klareskog, Anca Irinel Catrina, Stephen Paget, Rheumatoid arthritis, The Lancet, 2009, 373, 9664, 659

    CrossRef

  133. 133
    Cristiano Alessandri, Fabrizio Conti, Paola Conigliaro, Riccardo Mancini, Laura Massaro, Guido Valesini, Seronegative Autoimmune Diseases, Annals of the New York Academy of Sciences, 2009, 1173, 1
    Direct Link:
  134. 134
    H. Uysal, R. Bockermann, K. S. Nandakumar, B. Sehnert, E. Bajtner, A. Engstrom, G. Serre, H. Burkhardt, M. M.G.M. Thunnissen, R. Holmdahl, Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis, Journal of Experimental Medicine, 2009, 206, 2, 449

    CrossRef

  135. 135
    Leticia Cano, Daniel G. Arkfeld, Targeted Synovial Fluid Proteomics for Biomarker Discovery in Rheumatoid Arthritis, Clinical Proteomics, 2009, 5, 2, 75

    CrossRef

  136. 136
    Jochen Zwerina, Roland Axmann, Bernhard Manger, Georg Schett, The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome, Arthritis & Rheumatism, 2009, 60, 2
    Direct Link:
  137. 137
    John B. Imboden, The Immunopathogenesis of Rheumatoid Arthritis, Annual Review of Pathology: Mechanisms of Disease, 2009, 4, 1, 417

    CrossRef

  138. 138
    Hani El-Gabalawy, The preclinical stages of RA: lessons from human studies and animal models, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 49

    CrossRef

  139. 139
    Michael P. M. van der Linden, Diane van der Woude, Andreea Ioan-Facsinay, E. W. Nivine Levarht, Gerrie Stoeken-Rijsbergen, Tom W. J. Huizinga, René E. M. Toes, Annette H. M. van der Helm-van Mil, Value of anti–modified citrullinated vimentin and third-generation anti–cyclic citrullinated peptide compared with second-generation anti–cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis, Arthritis & Rheumatism, 2009, 60, 8
    Direct Link:
  140. 140
    Jorge Rojas-Serrano, Rubén Burgos-Vargas, Leticia Lino Pérez, Conrado García García, Francisco Moctezuma, Janitzia Vázquez-Mellado, Very recent onset arthritis: the value of initial rheumatologist evaluation and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis, Clinical Rheumatology, 2009, 28, 10, 1135

    CrossRef

  141. 141
    Solbritt Rantapää-Dahlqvist, What happens before the onset of rheumatoid arthritis?, Current Opinion in Rheumatology, 2009, 21, 3, 272

    CrossRef

  142. 142
    Nathan J. Zvaifler, Rheumatoid Arthritis, 2009,

    CrossRef

  143. 143
    Günter Steiner, Rheumatoid Arthritis, 2009,

    CrossRef

  144. 144
    Tom W.J. Huizinga, Ferdinand C. Breedveld, Rheumatoid Arthritis, 2009,

    CrossRef

  145. 145
    Klaus P. Machold, Josef S. Smolen, Rheumatoid Arthritis, 2009,

    CrossRef

  146. 146
    Lars Klareskog, Johan Rönnelid, Lars Alfredsson, Rheumatoid Arthritis, 2009,

    CrossRef

  147. 147
    Shouvik Dass, Edward M. Vital, Paul Emery, Rheumatoid Arthritis, 2009,

    CrossRef

  148. 148
    Kei Ohnuma, Osamu Hosono, Hiroshi Kawasaki, Noritada Yoshikawa, Tomoki Katayose, Naoki Oyaizu, Hirotoshi Tanaka, Chikao Morimoto, An adult case of Henoch-Schönlein purpura complicating common peroneal nerve mononeuropathy, Modern Rheumatology, 2008, 19, 1, 73

    CrossRef

  149. 149
    Naoki Inui, Noriyuki Enomoto, Takafumi Suda, Yasunori Kageyama, Hiroshi Watanabe, Kingo Chida, Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis, Clinical Biochemistry, 2008, 41, 13, 1074

    CrossRef

  150. 150
    Churl Hyun Im, Eun Ha Kang, Hee Jung Ryu, Jung Hwa Lee, Eun Young Lee, Yun Jong Lee, Eun Bong Lee, Yeong Wook Song, Anti-cyclic citrullinated peptide antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared epitope status, Rheumatology International, 2008, 29, 3, 251

    CrossRef

  151. 151
    Walther J. Van Venrooij, Joyce J.B.C. Van Beers, Ger J.M. Pruijn, Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis, Annals of the New York Academy of Sciences, 2008, 1143, 1
    Direct Link:
  152. 152
    Lars Klareskog, Mona Widhe, Monika Hermansson, Johan Rönnelid, Antibodies to citrullinated proteins in arthritis: pathology and promise, Current Opinion in Rheumatology, 2008, 20, 3, 300

    CrossRef

  153. 153
    Karin Lundberg, Andrew Kinloch, Benjamin A. Fisher, Natalia Wegner, Robin Wait, Peter Charles, Ted R. Mikuls, Patrick J. Venables, Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase, Arthritis & Rheumatism, 2008, 58, 10
    Direct Link:
  154. 154
    Irun R. Cohen, Lars Klareskog, Antiinflammatory therapy for rheumatoid arthritis?, Arthritis & Rheumatism, 2008, 58, 1
    Direct Link:
  155. 155
    J. A. Hill, D. A. Bell, W. Brintnell, D. Yue, B. Wehrli, A. M. Jevnikar, D. M. Lee, W. Hueber, W. H. Robinson, E. Cairns, Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice, Journal of Experimental Medicine, 2008, 205, 4, 967

    CrossRef

  156. 156
    Kutty Selva Nandakumar, Estelle Bajtner, Leigh Hill, Beate Böhm, Merrill J. Rowley, Harald Burkhardt, Rikard Holmdahl, Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation, Arthritis & Rheumatism, 2008, 58, 1
    Direct Link:
  157. 157
    Marc C. Levesque, E. William St. Clair, B cell–directed therapies for autoimmune disease and correlates of disease response and relapse, Journal of Allergy and Clinical Immunology, 2008, 121, 1, 13

    CrossRef

  158. 158
    Stefan Carlsen, Kutty Selva Nandakumar, Johan Bäcklund, Jens Holmberg, Malin Hultqvist, Mikael Vestberg, Rikard Holmdahl, Cartilage oligomeric matrix protein induction of chronic arthritis in mice, Arthritis & Rheumatism, 2008, 58, 7
    Direct Link:
  159. 159
    V. Goeb, P. Dieude, R. Daveau, M. Thomas-L'Otellier, F. Jouen, F. Hau, P. Boumier, F. Tron, D. Gilbert, P. Fardellone, F. Cornelis, X. Le Loet, O. Vittecoq, Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis, Rheumatology, 2008, 47, 8, 1208

    CrossRef

  160. 160
    Shunsuke Mori, Hiromichi Naito, Sumire Ohtani, Tohru Yamanaka, Mineharu Sugimoto, Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis, Clinical Rheumatology, 2008, 28, 3, 277

    CrossRef

  161. 161
    Lars Klareskog, Johan Rönnelid, Karin Lundberg, Leonid Padyukov, Lars Alfredsson, Immunity to Citrullinated Proteins in Rheumatoid Arthritis, Annual Review of Immunology, 2008, 26, 1, 651

    CrossRef

  162. 162
    Andreea Ioan-Facsinay, Annemiek Willemze, David B. Robinson, Christine A. Peschken, Janet Markland, Diane van der Woude, Brenda Elias, Henri A. Ménard, Marianna Newkirk, Marvin J. Fritzler, René E. M. Toes, Tom W. J. Huizinga, Hani S. El-Gabalawy, Marked differences in fine specificity and isotype usage of the anti–citrullinated protein antibody in health and disease, Arthritis & Rheumatism, 2008, 58, 10
    Direct Link:
  163. 163
    Nicole Fabien, Nils-Olivier Olsson, Joëlle Goetz, Catherine Johanet, Andrée Escande, Nathalie Bardin, Marielle Sanmarco, Chantal Andre, Alain Chevailler, René-Louis Humbel, Pascale Chretien, Jean-claude Monier, Françoise Fortenfant, Françoise Oksman, Marie-France Taillefer, Jean Sibilia, Prevalence of Autoantibodies to Cyclic Citrullinated Peptide in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: A French Multicenter Study, Clinical Reviews in Allergy & Immunology, 2008, 34, 1, 40

    CrossRef

  164. 164
    Anthony D. Woolf, Peter Brooks, Kristina Ã…kesson, Girish M. Mody, Prevention of musculoskeletal conditions in the developing world, Best Practice & Research Clinical Rheumatology, 2008, 22, 4, 759

    CrossRef

  165. You have free access to this content165
    Stijn Lambrecht, Kelly Tilleman, Dirk Elewaut, Dieter Deforce, Proteomics in rheumatology: The beginning of a fairy tale?, PROTEOMICS - Clinical Applications, 2008, 2, 3
    Direct Link:
  166. 166
    Zoltán Szekanecz, Gabriella Lakos, Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika, Expert Opinion on Medical Diagnostics, 2008, 2, 9, 1083

    CrossRef

  167. 167
    Münevver Serdaroğlu, Haşim Çakırbay, Orhan Değer, Sevil Cengiz, Sibel Kul, The association of anti-CCP antibodies with disease activity in rheumatoid arthritis, Rheumatology International, 2008, 28, 10, 965

    CrossRef

  168. 168
    Theodorus van den Broek, John RP Tesser, Salvatore Albani, The evolution of biomarkers in rheumatoid arthritis: From clinical research to clinical care, Expert Opinion on Biological Therapy, 2008, 8, 11, 1773

    CrossRef

  169. 169
    Laura M. Stinton, Marvin J. Fritzler, A clinical approach to autoantibody testing in systemic autoimmune rheumatic disorders, Autoimmunity Reviews, 2007, 7, 1, 77

    CrossRef

  170. 170
    Judith A. M. Wessels, Sjoerd M. van der Kooij, Saskia le Cessie, Wietske Kievit, Pilar Barerra, Cornelia F. Allaart, Tom W. J. Huizinga, Henk-Jan Guchelaar, A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 6
    Direct Link:
  171. 171
    Michael H. Schiff, Kathryn F. Hobbs, Timothy Gensler, Gregory F. Keenan, A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis, Current Medical Research and Opinion, 2007, 23, 5, 961

    CrossRef

  172. 172
    I. G. Silveira, R. W. Burlingame, C. A. Mühlen, A. L. Bender, H. L. Staub, Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF, Clinical Rheumatology, 2007, 26, 11, 1883

    CrossRef

  173. 173
    Walther J. Venrooij, Albert J. W. Zendman, Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis, Clinical Reviews in Allergy & Immunology, 2007, 34, 1, 36

    CrossRef

  174. 174
    Zoltán Szekanecz, Lilla Soós, Zoltán Szabó, Andrea Fekete, Anikó Kapitány, Anikó Végvári, Sándor Sipka, Gabriella Szücs, Sándor Szántó, Gabriella Lakos, Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?, Clinical Reviews in Allergy & Immunology, 2007, 34, 1, 26

    CrossRef

  175. 175
    Nicola Bizzaro, Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis, Clinical Chemistry and Laboratory Medicine, 2007, 45, 2, 150

    CrossRef

  176. 176
    V. Michael Holers, Antibodies to citrullinated proteins: Pathogenic and diagnostic significance, Current Rheumatology Reports, 2007, 9, 5, 396

    CrossRef

  177. 177
    Hannah Poulsom, Peter J. Charles, Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis, Clinical Reviews in Allergy & Immunology, 2007, 34, 1, 4

    CrossRef

  178. 178
    Luiz Sergio Guedes-Barbosa, Cristovão Mangueira, Morton Scheinberg, Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association, Clinical Rheumatology, 2007, 27, 4, 515

    CrossRef

  179. 179
    Alejandro Balsa, Dora Pascual-Salcedo, Javier Martín, Anticuerpos anticitrulina en la artritis reumatoide, Medicina Clínica, 2007, 128, 17, 668

    CrossRef

  180. 180
    Yoe Kie Onno Teng, Jacob M van Laar, Anticyclic citrullinated peptide antibodies: the footprint of autoreactive plasma cells in synovium?, Future Rheumatology, 2007, 2, 6, 577

    CrossRef

  181. 181
    Karen M. Semchuk, Alan M. Rosenberg, Helen H. McDuffie, Allan J. Cessna, Punam Pahwa, Donald G. Irvine, Antinuclear Antibodies and Bromoxynil Exposure in a Rural Sample, Journal of Toxicology and Environmental Health, Part A, 2007, 70, 7, 638

    CrossRef

  182. 182
    Nicola Bizzaro, Renato Tozzoli, Yehuda Shoenfeld, Are we at a stage to predict autoimmune rheumatic diseases?, Arthritis & Rheumatism, 2007, 56, 6
    Direct Link:
  183. 183
    Snaevar Sigurdsson, Leonid Padyukov, Fina A. S. Kurreeman, Ulrika Liljedahl, Ann-Christin Wiman, Lars Alfredsson, René Toes, Johan Rönnelid, Lars Klareskog, Tom W. J. Huizinga, Gunnar Alm, Ann-Christine Syvänen, Lars Rönnblom, Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 7
    Direct Link:
  184. 184
    Günter Steiner, Auto-antibodies and autoreactive T-cells in rheumatoid arthritis, Clinical Reviews in Allergy & Immunology, 2007, 32, 1, 23

    CrossRef

  185. 185
    Günter Steiner, Auto-antibodies and autoreactive T-cells in rheumatoid arthritis, Clinical Reviews in Allergy & Immunology, 2007, 32, 1, 23

    CrossRef

  186. 186
    Nicola Bizzaro, Autoantibodies as predictors of disease: The clinical and experimental evidence, Autoimmunity Reviews, 2007, 6, 6, 325

    CrossRef

  187. 187
    Eriko Kudo-Tanaka, Shiro Ohshima, Masaru Ishii, Toru Mima, Masato Matsushita, Naoto Azuma, Yoshinori Harada, Yoshinori Katada, Hitomi Ikeue, Mitsuko Umeshita-Sasai, Kunio Miyatake, Yukihiko Saeki, Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis, Clinical Rheumatology, 2007, 26, 10, 1627

    CrossRef

  188. 188
    E. Feist, K. Egerer, G.-R. Burmester, Autoantikörperprofile bei der rheumatoiden Arthritis, Zeitschrift für Rheumatologie, 2007, 66, 3, 212

    CrossRef

  189. 189
    Ralph C. Williams, Autoimmune disease etiology—a perplexing paradox or a turning leaf?, Autoimmunity Reviews, 2007, 6, 4, 204

    CrossRef

  190. 190
    Juha Risteli, Marja-Kaisa Koivula, Leila Risteli, Citrullinated collagens in the pathogenesis of rheumatoid arthritis, Expert Review of Clinical Immunology, 2007, 3, 2, 187

    CrossRef

  191. 191
    Marcus Ronninger, Henrik Källberg, Emeli Lundström, Annmarie Lindahl, Lars Klareskog, Lars Alfredsson, Leonid Padyukov, Complexity of a complex disease; understanding genes, environment and immunity in rheumatoid arthritis development, Future Rheumatology, 2007, 2, 5, 485

    CrossRef

  192. 192
    Nicola Bizzaro, Marilina Tampoia, Diagnostic Accuracy of Immunoassays for the Detection of Antibodies to Citrullinated Proteins, Clinical Reviews in Allergy & Immunology, 2007, 34, 1, 16

    CrossRef

  193. 193
    Rim Sghiri, Elyes Bouagina, Hela Zaglaoui, Hajer Mestiri, Latifa Harzallah, Imed Harrabi, Mehdi Ghannouchi, Faycel Mokhtar, Ibtissem Ghedira, Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, Rheumatology International, 2007, 27, 12, 1125

    CrossRef

  194. 194
    Sung-Hoon Park, Ji-Young Kim, Seong-Kyu Kim, Jung-Yoon Choe, Sang Kyung Kim, Im-Hee Shin, Diagnostic Significance of Anti-CCP Antibody in Korean Early Rheumatoid Arthritis, The Journal of the Korean Rheumatism Association, 2007, 14, 3, 227

    CrossRef

  195. 195
    Lindsey A. Criswell, Wei V. Chen, Damini Jawaheer, Raymond F. Lum, Mark H. Wener, Xiangjun Gu, Peter K. Gregersen, Christopher I. Amos, Dissecting the heterogeneity of rheumatoid arthritis through linkage analysis of quantitative traits, Arthritis & Rheumatism, 2007, 56, 1
    Direct Link:
  196. 196
    Annette H. M. van der Helm-van Mil, Tom W. J. Huizinga, René R. P. de Vries, René E. M. Toes, Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 6
    Direct Link:
  197. 197
    R. Wu, O. Shovman, Y. Zhang, B. Gilburd, G. Zandman-Goodard, Yehuda Shoenfeld, Increased Prevalence of Anti-Third Generation Cyclic Citrullinated Peptide Antibodies in Patients With Rheumatoid Arthritis and CREST Syndrome, Clinical Reviews in Allergy & Immunology, 2007, 32, 1, 47

    CrossRef

  198. 198
    R. Wu, O. Shovman, Y. Zhang, B. Gilburd, G. Zandman-Goodard, Yehuda Shoenfeld, Increased Prevalence of Anti-Third Generation Cyclic Citrullinated Peptide Antibodies in Patients With Rheumatoid Arthritis and CREST Syndrome, Clinical Reviews in Allergy & Immunology, 2007, 32, 1, 47

    CrossRef

  199. 199
    Gabriella Szűcs, Korai arthritisek, Orvosi Hetilap, 2007, 148, 22, 1011

    CrossRef

  200. 200
    K. Hartung, H.-P. Seelig, Labordiagnostik der systemischen Autoimmunerkrankungen, Zeitschrift für Rheumatologie, 2007, 66, 3, 225

    CrossRef

  201. 201
    Saurabh Ghosh, Marie-Claude Babron, Linkage analyses of rheumatoid arthritis and related quantitative phenotypes: the GAW15 experience, Genetic Epidemiology, 2007, 31, S1
    Direct Link:
  202. 202
    Rikard Holmdahl, Primer: comparative genetics of animal models of arthritis—a tool to resolve complexity, Nature Clinical Practice Rheumatology, 2007, 3, 2, 104

    CrossRef

  203. 203
    Lars Klareskog, Leonid Padyukov, Lars Alfredsson, Smoking as a trigger for inflammatory rheumatic diseases, Current Opinion in Rheumatology, 2007, 19, 1, 49

    CrossRef

  204. 204
    Xiaobo Wu, Fei Shih, John P. Atkinson, Systemic humoral autoimmunity but joint-specific inflammation: The syndrome of rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 9
    Direct Link:
  205. 205
    J. Smolen, D. Aletaha, The burden of rheumatoid arthritis and access to treatment: a medical overview, The European Journal of Health Economics, 2007, 8, S2, 39

    CrossRef

  206. 206
    Annette H. M. van der Helm-van Mil, Kirsten N. Verpoort, Saskia le Cessie, Tom W. J. Huizinga, René R. P. de Vries, René E. M. Toes, The HLA–DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide, Arthritis & Rheumatism, 2007, 56, 2
    Direct Link:
  207. 207
    Allan S. Wiik, The immune response to citrullinated proteins in patients with rheumatoid arthritis, Clinical Reviews in Allergy & Immunology, 2007, 32, 1, 13

    CrossRef

  208. 208
    Allan S. Wiik, The immune response to citrullinated proteins in patients with rheumatoid arthritis, Clinical Reviews in Allergy & Immunology, 2007, 32, 1, 13

    CrossRef

  209. 209
    Rainer H. Straub, Hugo O. Besedovsky, Adriana del Rey, Warum gibt es analoge Krankheitsmechanismen bei chronisch entzündlichen Krankheiten?, Wiener klinische Wochenschrift, 2007, 119, 15-16, 444

    CrossRef

  210. 210
    Lisa GM van Baarsen, Tineke CTM van der Pouw-Kraan, Cornelis L Verweij, A genomic view of subtypes in rheumatoid arthritis: towards personalized medicine, Future Rheumatology, 2006, 1, 3, 311

    CrossRef

  211. 211
    Lars Klareskog, Patrik Stolt, Karin Lundberg, Henrik Källberg, Camilla Bengtsson, Johan Grunewald, Johan Rönnelid, Helena Erlandsson Harris, Ann-Kristin Ulfgren, Solbritt Rantapää-Dahlqvist, Anders Eklund, Leonid Padyukov, Lars Alfredsson, A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination, Arthritis & Rheumatism, 2006, 54, 1
    Direct Link:
  212. 212
    Kathryn Dao, John J. Cush, Acute polyarthritis, Best Practice & Research Clinical Rheumatology, 2006, 20, 4, 653

    CrossRef

  213. 213
    Wonhee Hur, Mi-La Cho, Seung Kew Yoon, So Yeon Kim, Ji-Hyeon Ju, Joo-Yeon Jhun, Seong-Bum Heo, Young-Mee Moon, So-Youn Min, Sung-Hwan Park, Ho-Youn Kim, Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice, Immunology Letters, 2006, 106, 2, 154

    CrossRef

  214. 214
    Cengiz Korkmaz, Tercan Us, Timuçin Kaşifoğlu, Yurdanur Akgün, Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations, Clinical Biochemistry, 2006, 39, 10, 961

    CrossRef

  215. 215
    Toshihiro MATSUI, Antibodies to citrullinated proteins in rheumatoid arthritis, Japanese Journal of Clinical Immunology, 2006, 29, 2, 49

    CrossRef

  216. 216
    Bengt-Olof Nilsson, Thomas Skogh, Jan Ernerudh, Boo Johansson, Sture Löfgren, Anders Wikby, Charlotte Dahle, Antinuclear antibodies in the oldest-old women and men, Journal of Autoimmunity, 2006, 27, 4, 281

    CrossRef

  217. 217
    V Michael Holers, Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?, Nature Clinical Practice Rheumatology, 2006, 2, 8, 400

    CrossRef

  218. 218
    Margarita Rodríguez-Mahou, Francisco Javier López-Longo, Silvia Sánchez-Ramón, Ana Estecha, Aurea García-Segovia, Juan José Rodríguez-Molina, Luis Carreño, Eduardo Fernández-Cruz, Association of anti–cyclic citrullinated peptide and anti-Sa/citrullinated vimentin autoantibodies in rheumatoid arthritis, Arthritis Care & Research, 2006, 55, 4
    Direct Link:
  219. 219
    D. Mewar, A.G. Wilson, Autoantibodies in rheumatoid arthritis: a review, Biomedicine & Pharmacotherapy, 2006, 60, 10, 648

    CrossRef

  220. 220
    Walther J. van Venrooij, Albert J.W. Zendman, Ger J.M. Pruijn, Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis, Autoimmunity Reviews, 2006, 6, 1, 37

    CrossRef

  221. 221
    Jeffrey L. Browning, B cells move to centre stage: novel opportunities for autoimmune disease treatment, Nature Reviews Drug Discovery, 2006, 5, 7, 564

    CrossRef

  222. 222
    Jonathan C. W. Edwards, Geraldine Cambridge, B-cell targeting in rheumatoid arthritis and other autoimmune diseases, Nature Reviews Immunology, 2006, 6, 5, 394

    CrossRef

  223. 223
    Tineke Cantaert, Leen De Rycke, Tim Bongartz, Eric L. Matteson, Paul P. Tak, Anthony P. Nicholas, Dominique Baeten, Citrullinated proteins in rheumatoid arthritis: Crucial … but not sufficient!, Arthritis & Rheumatism, 2006, 54, 11
    Direct Link:
  224. 224
    Ryo Yamada, Akari Suzuki, Kazuhiko Yamamoto, Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, Future Rheumatology, 2006, 1, 2, 249

    CrossRef

  225. 225
    Rudolf Mierau, Ekkehard Genth, Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis, Clinical Chemistry and Laboratory Medicine, 2006, 44, 2, 138

    CrossRef

  226. 226
    C. J. Edwards, C. Cooper, Early environmental factors and rheumatoid arthritis, Clinical & Experimental Immunology, 2006, 143, 1
    Direct Link:
  227. 227
    Lars Klareskog, Leonid Padyukov, Johan Rönnelid, Lars Alfredsson, Genes, environment and immunity in the development of rheumatoid arthritis, Current Opinion in Immunology, 2006, 18, 6, 650

    CrossRef

  228. 228
    G. Orozco, B. Rueda, J. Martin, Genetic basis of rheumatoid arthritis, Biomedicine & Pharmacotherapy, 2006, 60, 10, 656

    CrossRef

  229. 229
    Annette HM van der Helm-van Mil, Tom WJ Huizinga, Genetics and clinical characteristics to predict rheumatoid arthritis: where are we now and what are the future prospects?, Future Rheumatology, 2006, 1, 1, 79

    CrossRef

  230. 230
    René R.P. de Vries, Tom W.J. Huizinga, René E.M. Toes, HLA and RA Revisited: Citrullinated Food for the SE Hypothesis, the DR6 Effect, and NIMA, Human Immunology, 2006, 67, 6, 454

    CrossRef

  231. 231
    M Mubashir Ahmed, Eisha Mubashir, Robert E. Wolf, Samina Hayat, Vicky Hall, Runhua Shi, Seth Mark Berney, Impact of Treatment with Infliximab on Anticyclic Citrullinated Peptide Antibody and Rheumatoid Factor in Patients with Rheumatoid Arthritis, Southern Medical Journal, 2006, 99, 11, 1209

    CrossRef

  232. 232
    K. N. Verpoort, C. M. Jol-van der Zijde, E. A. M. Papendrecht-van der Voort, A. Ioan-Facsinay, J. W. Drijfhout, M. J. D. van Tol, F. C. Breedveld, T. W. J. Huizinga, R. E. M. Toes, Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response, Arthritis & Rheumatism, 2006, 54, 12
    Direct Link:
  233. 233
    Lars Klareskog, Leonid Padyukov, Johnny Lorentzen, Lars Alfredsson, Mechanisms of Disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis, Nature Clinical Practice Rheumatology, 2006, 2, 8, 425

    CrossRef

  234. 234
    Glinda S. Cooper, Christine G. Parks, Peter S. Schur, Patricia A. Fraser, Occupational and Environmental Associations with Antinuclear Antibodies in a General Population Sample, Journal of Toxicology and Environmental Health, Part A, 2006, 69, 23, 2063

    CrossRef

  235. 235
    Andrew J Kinloch, Karin E Lundberg, David Moyes, Patrick J Venables, Pathogenic role of antibodies to citrullinated proteins in rheumatoid arthritis, Expert Review of Clinical Immunology, 2006, 2, 3, 365

    CrossRef

  236. 236
    Josef S Smolen, Daniel Aletaha, Klaus Machold, Valerie Nell, Kurt Redlich, Georg Schett, Tanja Stamm, Günter Steiner, Pre-arthritis: a concept whose time has come, Future Rheumatology, 2006, 1, 1, 1

    CrossRef

  237. 237
    R. Mierau, E. Genth, Sklerodermie-assoziierte Autoantikörper – klinische und diagnostische Relevanz, Zeitschrift für Rheumatologie, 2006, 65, 4, 279

    CrossRef

  238. 238
    Jennifer D. Gorman, Smoking and rheumatoid arthritis: Another reason to just say no, Arthritis & Rheumatism, 2006, 54, 1
    Direct Link:
  239. 239
    M.W. Hayman, M.T.A. van Beijnen, L.K. Stamp, M.B. Spellerberg, J.L. O'Donnell, Soluble human leukocyte antigen: A diagnostic indicator of rheumatoid arthritis?, Journal of Immunological Methods, 2006, 315, 1-2, 19

    CrossRef

  240. 240
    Dan Caspi, Marina Anouk, Itzhak Golan, Daphna Paran, Ilana Kaufman, Irena Wigler, David Levartovsky, Irena Litinsky, Ori Elkayam, Synovial fluid levels of anti–cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis, Arthritis Care & Research, 2006, 55, 1
    Direct Link:
  241. 241
    Peter Boross, J. Sjef Verbeek, The complex role of Fcγ receptors in the pathology of arthritis, Springer Seminars in Immunopathology, 2006, 28, 4, 339

    CrossRef

  242. 242
    Annette H. M. van der Helm-van Mil, Kirsten N. Verpoort, Ferdinand C. Breedveld, Tom W. J. Huizinga, René E. M. Toes, René R. P. de Vries, The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis, Arthritis & Rheumatism, 2006, 54, 4
    Direct Link:
  243. 243
    Jon T Giles, Wendy Post, Roger S Blumenthal, Joan M Bathon, Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis, Nature Clinical Practice Rheumatology, 2006, 2, 6, 320

    CrossRef

  244. 244
    Sally Cox, Paul Emery, Use of prognostic markers in early rheumatoid arthritis to identify patients at risk of destructive disease, Expert Review of Clinical Immunology, 2006, 2, 6, 853

    CrossRef

  245. 245
    Claire Gorman, Timothy Vyse, Andrew Cope, What does the immunogenetic basis of rheumatoid arthritis teach us about the immunobiology of the disease?, Expert Review of Clinical Immunology, 2006, 2, 5, 717

    CrossRef

  246. 246
    Yuta Kochi, Ryo Yamada, Akari Suzuki, John B Harley, Senji Shirasawa, Tetsuji Sawada, Sang-Cheol Bae, Shinya Tokuhiro, Xiaotian Chang, Akihiro Sekine, Atsushi Takahashi, Tatsuhiko Tsunoda, Yozo Ohnishi, Kenneth M Kaufman, Changsoo Paul Kang, Changwon Kang, Shigeru Otsubo, Wako Yumura, Akio Mimori, Takao Koike, Yusuke Nakamura, Takehiko Sasazuki, Kazuhiko Yamamoto, A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities, Nature Genetics, 2005, 37, 5, 478

    CrossRef

  247. 247
    Peter Härle, Daniel Möbius, Daniel J. J. Carr, Jürgen Schölmerich, Rainer H. Straub, An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen–induced arthritis, Arthritis & Rheumatism, 2005, 52, 4
    Direct Link:
  248. 248
    B. Vander Cruyssen, I. Peene, T. Cantaert, I.E.A. Hoffman, L. De Rycke, E.M. Veys, F. De Keyser, Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor, Autoimmunity Reviews, 2005, 4, 7, 468

    CrossRef

  249. 249
    Belén García-Berrocal, Concepción González, Marta Pérez, José A. Navajo, Isabel Moreta, Carmen Dávila, José M. González-Buitrago, Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients, Clinica Chimica Acta, 2005, 354, 1-2, 123

    CrossRef

  250. 250
    Marilina Tampoia, Vincenzo Brescia, Antonietta Fontana, Piera Maggiolini, Giovanni Lapadula, Nicola Pansini, Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: Analytical performance and clinical correlations, Clinica Chimica Acta, 2005, 355, 1-2, 137

    CrossRef

  251. 251
    Elizabeth D. Ferucci, Darcy S. Majka, Lezlie A. Parrish, Marta B. Moroldo, Mary Ryan, Murray Passo, Susan D. Thompson, Kevin D. Deane, Marian Rewers, William P. Arend, David N. Glass, Jill M. Norris, V. Michael Holers, Antibodies against cyclic citrullinated peptide are associated with HLA–DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 1
    Direct Link:
  252. 252
    D. Mewar, D. J. Moore, S. Young-Min, M. L. Bertolaccini, M. A. Khamashta, P. F. Watson, A. G. Wilson, Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 12
    Direct Link:
  253. 253
    ALEXANDER GREINER, HERBERT PLISCHKE, HERBERT KELLNER, RUDOLF GRUBER, Association of Anti-Cyclic Citrullinated Peptide Antibodies, Anti-Citrullin Antibodies, and IgM and IgA Rheumatoid Factors with Serological Parameters of Disease Activity in Rheumatoid Arthritis, Annals of the New York Academy of Sciences, 2005, 1050, 1
    Direct Link:
  254. 254
    Kirsten N. Verpoort, Floris A. van Gaalen, Annette H. M. van der Helm-van Mil, Geziena M. T. Schreuder, Ferdinand C. Breedveld, Tom W. J. Huizinga, Rene R. P. de Vries, Rene E. M. Toes, Association of HLA–DR3 with anti–cyclic citrullinated peptide antibody–negative rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 10
    Direct Link:
  255. 255
    F. Hiepe, T. Dörner, Autoantikörper und die Zellen, die sie machen, Zeitschrift für Rheumatologie, 2005, 64, 6, 389

    CrossRef

  256. 256
    C. Berek, B-Lymphozyten—, Zeitschrift für Rheumatologie, 2005, 64, 6, 383

    CrossRef

  257. 257
    Sarah L. Mackie, Edward M. Vital, Frederique Ponchel, Paul Emery, Co-stimulatory blockade as therapy for rheumatoid arthritis, Current Rheumatology Reports, 2005, 7, 5, 400

    CrossRef

  258. 258
    Rudolf Mierau, Ekkehard Genth, Diagnostik und Prognostik der frühen rheumatoiden Arthritis unter besonderer Berücksichtigung der Labor-Analytik Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis, LaboratoriumsMedizin, 2005, 29, 4, 251

    CrossRef

  259. 259
    ROBERT LYONS, SONALI NARAIN, CODY NICHOLS, MINORU SATOH, WESTLEY H. REEVES, Effective Use of Autoantibody Tests in the Diagnosis of Systemic Autoimmune Disease, Annals of the New York Academy of Sciences, 2005, 1050, 1
    Direct Link:
  260. 260
    Antonio Fernández-Suárez, Sonsoles Reneses, Ingeborg Wichmann, Rita Criado, Antonio Núñez, Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis, Clinical Chemistry and Laboratory Medicine, 2005, 43, 11, 1234

    CrossRef

  261. 261
    O SHOVMAN, B GILBURD, O BARZILAI, E SHINAR, B LARIDA, G ZANDMAN-GODDARD, S R BINDER, Y SHOENFELD, Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies, Annals of the New York Academy of Sciences, 2005, 1050, 1
    Direct Link:
  262. 262
    Ahuva Nissim, Paul G. Winyard, Valerie Corrigall, Rewas Fatah, David Perrett, Gabriel Panayi, Yuti Chernajovsky, Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint, Arthritis & Rheumatism, 2005, 52, 12
    Direct Link:
  263. 263
    Kazuhiko Yamamoto, Ryo Yamada, Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis, Journal of Autoimmunity, 2005, 25, 12

    CrossRef

  264. 264
    Ilka Senkpiehl, Matthias Marget, Martina Wedler, Stefan Jenisch, Joachim Georgi, Dietrich Kabelitz, Jörg Steinmann, HLA-DRB1 and Anti-Cyclic Citrullinated Peptide Antibody Production in Rheumatoid Arthritis, International Archives of Allergy and Immunology, 2005, 137, 4, 315

    CrossRef

  265. 265
    Rainer H. Straub, Firdaus S. Dhabhar, Johannes W. J. Bijlsma, Maurizio Cutolo, How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 1
    Direct Link:
  266. 266
    Harald Burkhardt, Bettina Sehnert, Robert Bockermann, Åke Engström, Jochen R. Kalden, Rikard Holmdahl, Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis, European Journal of Immunology, 2005, 35, 5
    Direct Link:
  267. 267
    Gary S. Firestein, Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis, JCR: Journal of Clinical Rheumatology, 2005, 11, Supplement, S39

    CrossRef

  268. 268
    A. T. Masi, J. C. Aldag, Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase?, Scandinavian Journal of Rheumatology, 2005, 34, 5, 342

    CrossRef

  269. 269
    Walther J van Venrooij, Leo BA van de Putte, Is assaying autoantibodies useful for diagnosing early rheumatoid arthritis?, Nature Clinical Practice Rheumatology, 2005, 1, 1, 4

    CrossRef

  270. 270
    Nouha Raissouni, Laure Gossec, Xavier Ayral, Maxime Dougados, New concepts in the diagnosis and treatment of recent-onset polyarthritis, Joint Bone Spine, 2005, 72, 2, 119

    CrossRef

  271. 271
    Stephen J. Martino, Stephen A. Paget, On the Importance of Early Arthritis Centers, HSS Journal, 2005, 1, 1, 107

    CrossRef

  272. 272
    Ryo Yamada, Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis, Autoimmunity Reviews, 2005, 4, 4, 201

    CrossRef

  273. 273
    M. Tampoia, V. Brescia, A. Fontana, P. Maggiolini, A. Zucano, N. Pansini, Proteomic: New advances in the diagnosis of rheumatoid arthritis, Clinica Chimica Acta, 2005, 357, 2, 219

    CrossRef

  274. 274
    K. A. Finucane, C. B. Archer, Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus, Clinical and Experimental Dermatology, 2005, 30, 2
    Direct Link:
  275. 275
    René R.P. de Vries, Tom W.J. Huizinga, René E.M. Toes, Redefining the HLA and RA association: To be or not to be anti-CCP positive, Journal of Autoimmunity, 2005, 25, 21

    CrossRef

  276. 276
    Tom W. J. Huizinga, Christopher I. Amos, Annette H. M. van der Helm-van Mil, Wei Chen, Floris A. van Gaalen, Damini Jawaheer, Geziena M. T. Schreuder, Mark Wener, Ferdinand C. Breedveld, Naila Ahmad, Raymond F. Lum, Rene R. P. de Vries, Peter K. Gregersen, Rene E. M. Toes, Lindsey A. Criswell, Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA–DRB1 shared epitope for antibodies to citrullinated proteins, Arthritis & Rheumatism, 2005, 52, 11
    Direct Link:
  277. 277
    John J. Cush, Remodeling a Rheumatology Practice to Facilitate Early Referral, Rheumatic Disease Clinics of North America, 2005, 31, 4, 591

    CrossRef

  278. 278
    Alfonse T. Masi, Jean C. Aldag, Johannes W.G. Jacobs, Rheumatoid Arthritis: Neuroendocrine Immune Integrated Physiopathogenetic Perspectives and Therapy, Rheumatic Disease Clinics of North America, 2005, 31, 1, 131

    CrossRef

  279. 279
    Rainer H. Straub, Peter Härle, Sympathetic Neurotransmitters in Joint Inflammation, Rheumatic Disease Clinics of North America, 2005, 31, 1, 43

    CrossRef

  280. 280
    Leen De Rycke, Anthony P. Nicholas, Tineke Cantaert, Elli Kruithof, Joshua D. Echols, Bart Vandekerckhove, Eric M. Veys, Filip De Keyser, Dominique Baeten, Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis–specific humoral autoimmunity, Arthritis & Rheumatism, 2005, 52, 8
    Direct Link:
  281. 281
    O. Shovman, B. Gilburd, G. Zandman-Goddard, Y. Sherer, H. Orbach, R. Gerli, Y. Shoenfeld, The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis, Clinical and Developmental Immunology, 2005, 12, 3, 197

    CrossRef

  282. 282
    Isao MATSUMOTO, The pathogenic role and production system of autoantibody in rheumatoid arthritis, Japanese Journal of Clinical Immunology, 2005, 28, 6, 365

    CrossRef

  283. 283
    Olivier Vittecoq, Vincent Goeb, Xavier Le Loët, François Tron, The preclinical phase of rheumatoid arthritis and lupus, Joint Bone Spine, 2005, 72, 6, 443

    CrossRef

  284. 284
    Paulo J. Nicola, Hilal Maradit-Kremers, Véronique L. Roger, Steven J. Jacobsen, Cynthia S. Crowson, Karla V. Ballman, Sherine E. Gabriel, The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years, Arthritis & Rheumatism, 2005, 52, 2
    Direct Link:
  285. 285
    Kazuhisa Nozawa, Marvin J. Fritzler, Edward K.L. Chan, Unique and shared features of Golgi complex autoantigens, Autoimmunity Reviews, 2005, 4, 1, 35

    CrossRef

  286. 286
    Lorinda Chung, Paul J. Utz, Antibodies in scleroderma: Direct pathogenicity and phenotypic associations, Current Rheumatology Reports, 2004, 6, 2, 156

    CrossRef

  287. 287
    Leonie M. van Duivenvoorde, Pascale Louis-Plence, Florence Apparailly, Ellen I. H. van der Voort, Tom W. J. Huizinga, Christian Jorgensen, René E. M. Toes, Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor–stimulated dendritic cells, Arthritis & Rheumatism, 2004, 50, 10
    Direct Link:
  288. 288
    Floris A. Van Gaalen, Jill Van Aken, Tom W. J. Huizinga, Geziena M. Th. Schreuder, Ferdinand C. Breedveld, Eric Zanelli, Walther J. Van Venrooij, Cornelis L. Verweij, René E. M. Toes, René R. P. De Vries, Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis, Arthritis & Rheumatism, 2004, 50, 7
    Direct Link:
  289. 289
    T. R. Mikuls, J. R. O'Dell, J. A. Stoner, L. A. Parrish, W. P. Arend, J. M. Norris, V. M. Holers, Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti–cyclic citrullinated peptide antibody, Arthritis & Rheumatism, 2004, 50, 12
    Direct Link:
  290. 290
    Suzanne Nijenhuis, Albert J.W. Zendman, Erik R. Vossenaar, Ger J.M. Pruijn, Walther J. vanVenrooij, Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker, Clinica Chimica Acta, 2004, 350, 1-2, 17

    CrossRef

  291. 291
    F. A. van Gaalen, S. P. Linn-Rasker, W. J. van Venrooij, B. A. de Jong, F. C. Breedveld, C. L. Verweij, R. E. M. Toes, T. W. J. Huizinga, Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study, Arthritis & Rheumatism, 2004, 50, 3
    Direct Link:
  292. 292
    Robert H. Carter, B cells: New ways to inhibit their function in rheumatoid arthritis, Current Rheumatology Reports, 2004, 6, 5, 357

    CrossRef

  293. 293
    Mireille Sebbag, Sabine Chapuy-Regaud, Isabelle Auger, Elisabeth Petit-Texeira, Cyril Clavel, Leonor Nogueira, Christian Vincent, François Cornélis, Jean Roudier, Guy Serre, Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis, Joint Bone Spine, 2004, 71, 6, 493

    CrossRef

  294. 294
    F. JOUEN, O. VITTECOQ, F. LEGUILLOU, I. TABTI-TITON, J. F. MENARD, O. MEJJAD, S. POUPLIN, P. BOUMIER, P. FARDELLONE, A. GAYET, D. GILBERT, F. TRON, X. LE LOËT, Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis, Clinical & Experimental Immunology, 2004, 137, 3
    Direct Link:
  295. 295
    Chieko Kyogoku, Ward A. Ortmann, Annette Lee, Scott Selby, Victoria E.H. Carlton, Monica Chang, Paula Ramos, Emily C. Baechler, Franak M. Batliwalla, Jill Novitzke, Adrienne H. Williams, Clarence Gillett, Peter Rodine, Robert R. Graham, Kristin G. Ardlie, Patrick M. Gaffney, Kathy L. Moser, Michelle Petri, Ann B. Begovich, Peter K. Gregersen, Carl D. Langefeld, Timothy W. Behrens, Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE, The American Journal of Human Genetics, 2004, 75, 3, 504

    CrossRef

  296. 296
    Elliot D. Rosenstein, Robert A. Greenwald, Laura J. Kushner, Gerald Weissmann, Hypothesis: The Humoral Immune Response to Oral Bacteria Provides a Stimulus for the Development of Rheumatoid Arthritis, Inflammation, 2004, 28, 6, 311

    CrossRef

  297. 297
    Markus M. J. Nielen, Dirkjan Van Schaardenburg, Henk W. Reesink, Jos W. R. Twisk, Rob J. Van De Stadt, Irene E. Van Der Horst-Bruinsma, Truus De Gast, Moud R. Habibuw, Jan P. Vandenbroucke, Ben A. C. Dijkmans, Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis, Arthritis & Rheumatism, 2004, 50, 8
    Direct Link:
  298. 298
    Gerald Weissmann, Pathogenesis of Rheumatoid Arthritis, JCR: Journal of Clinical Rheumatology, 2004, 10, Supplement, S26

    CrossRef

  299. 299
    Stephen M Anderton, Post-translational modifications of self antigens: implications for autoimmunity, Current Opinion in Immunology, 2004, 16, 6, 753

    CrossRef

  300. 300
    Eva Baecklund, Johan Askling, Richard Rosenquist, Anders Ekbom, Lars Klareskog, Rheumatoid arthritis and malignant lymphomas, Current Opinion in Rheumatology, 2004, 16, 3, 254

    CrossRef

  301. 301
    S. Louis Bridges, Update on autoantibodies in rheumatoid arthritis, Current Rheumatology Reports, 2004, 6, 5, 343

    CrossRef

  302. 302
    Darcy S. Majka, V. Michael Holers, Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?, Arthritis & Rheumatism, 2003, 48, 10
    Direct Link:
View Full Article (HTML) Get PDF (95K)